Riskpilot← Back to searchSign inGet full accessjunoIVF ApS
APSActiveCVR 42485578Jens Kofods Gade 1Medical specialists activities · NACE 8622Est. 202113 employees
Revenue 2025
DKK 6,6M
+80% vs 2024
EBITDA margin
-11.1%
-4579% vs 2024
Equity ratio
-51.7%
Financial strength
Net profit 2025
DKK -918K
-175% vs 2024
| Revenue | DKK 6,6M | +80% |
| EBITDA | DKK -733K | -4579% |
| Net profit | DKK -918K | -175% |
| Total assets | DKK 4,7M | +2% |
| Equity | DKK -2,4M | -61% |
| Employees | 13 | — |
Legal name
junoIVF ApS
CVR number
42485578
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
22. juni 2021
Share capital
DKK 40.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at drive virksomhed ved at tilbyde IVF fertilitetsbehandling i en
high-end fertilitetsklinik med rådighed over den nyeste teknologi på fertilitetsområdet.
Address
Jens Kofods Gade 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 77 | 3.496 | 3.643 | 6.574 |
| Staff expenses | -1.771 | -2.901 | -3.627 | -3.504 |
| EBITDA | -1.694 | 595 | 16 | -733 |
| Depreciation & amort. | -0 | -447 | -444 | -444 |
| EBIT | -1.694 | 148 | -427 | -1.177 |
| Net financials | -0 | -0 | 0 | 0 |
| Profit before tax | -1.694 | 148 | -427 | -1.176 |
| Tax | -373 | 33 | -94 | -259 |
| Net profit | -1.321 | 115 | -333 | -918 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3.900 | 4.204 | 4.583 | 4.671 |
| Equity | -1.281 | -1.166 | -1.499 | -2.417 |
| Long-term debt | 53 | 53 | 301 | 0 |
| Short-term debt | 5.128 | 5.317 | 5.781 | 7.088 |
| Total debt | 5.181 | 5.370 | 6.082 | 7.088 |
EBITDA margin
-11.1%
This company
15.8%
Market median
-170% vs market
20222025
Equity ratio
-51.7%
This company
38.2%
Market median
-235% vs market
20222025
Return on equity
-91759700.0%
This company
18.4%
Market median
-498694122% vs market
20222025
Net profit margin
-14.0%
This company
8.1%
Market median
-273% vs market
20222025
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
20222025
Debt / equity
2.93×
This company
0.62×
Market median
-373% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-06-22 – 2022-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BM Management | Management | 2021 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2021 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Birgitte Rindom Holding ApS
junoIVF ApS Board members of junoIVF ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgitte Marianne Rindom | Management | 0 companies |